ライフサイエンスコーパス: country

1 f population geneticists in several European countries).

2 cost-effectiveness thresholds for low income countries).

3 lations, with some heterogeneity observed by country.

4 nza activity trends were determined for each country.

5 itations: The study was confined to a single country.

6 n all-cause pneumonia in older adults in any country.

7 nal immunization programs in many developing countries.

8 We identified 57 articles from 27 countries.

9 om 87 hospitals and cancer centres across 11 countries.

10 The Allergy Diary is available in 21 countries.

11 decreased across both measures in nearly all countries.

12 polio high-risk districts of 10 polio focus countries.

13 d for 6- to 7-year-olds in 132 centers in 57 countries.

14 into clinical practice guidelines in several countries.

15 th reports from low-income and middle-income countries.

16 s of calories and protein in many developing countries.

17 ng, as well as predict its prevalence across countries.

18 agement of drug-resistant tuberculosis in 90 countries.

19 treatment of recurrent glioblastoma in many countries.

20 ing vitamin A deficiency (VAD) in developing countries.

21 study was conducted at 8 hospitals across 2 countries.

22 posed by influenza in low- and middle-income countries.

23 ificant differences in growth of EFW between countries.

24 glected issue, particularly in resource-poor countries.

25 ETTINGS: ICUs located in nine Latin-American countries.

26 is restricted to adult women in high-income countries.

27 U prevalence estimates were identified in 83 countries.

28 tain regions of Spain or other Mediterranean countries.

29 d to levels currently achieved by forerunner countries.

30 61 of 70 studies for review, representing 27 countries.

31 were recruited from 200 trial centres in 22 countries.

32 oring vaccine underperformance in low-income countries.

33 of blindness in middle-income and low-income countries.

34 t per dollar consumed is lower for wealthier countries.

35 2 trial done at 29 centres in eight European countries.

36 rs, and are increasing in prevalence in most countries.

37 , phase 3 trial was done at 38 clinics in 13 countries.

38 183 hospitals and respiratory clinics in 14 countries.

39 ource settings, especially in less developed countries.

40 land and these other countries to additional countries.

41 than in previous periods in China or Western countries.

42 rd and 4th respectively among the productive countries.

43 sion programmes in other sub-Saharan African countries.

44 particularly in low-income and middle-income countries.

45 markets within Cameroon and five neighboring countries.

46 ups for analysis; Egypt versus other African countries.

47 prospective clinical trials soon in several countries.

48 We included 208140 patients from 57 countries.

49 3 travel and tropical medicine clinics in 30 countries.

50 K although multi-use is common in some other countries.

51 of life lost from 15 skin conditions in 188 countries.

52 ediatric and adult diabetes services in many countries.

53 ergy to Argas reflexus from several European countries.

54 but the evidence was largely from developed countries.

55 trol canine-transmitted rabies in developing countries.

56 3, multicentre study done at 143 sites in 17 countries.

57 s cause of newborn malformation in developed countries.

58 processing, and tissue transfer between the countries.

59 ibility to medical diagnostics in developing countries.

60 y Impairment in allergy) in 1288 users in 18 countries.

61 ction should be considered in dengue-endemic countries.

62 primary sources of dietary protein for many countries.

63 , limited data are available from low-income countries.

64 pen-label phase 3 study at 113 centres in 30 countries.

65 s, and co-circulate in increasing numbers of countries.

66 than that reported for patients in developed countries.

67 lower rates in middle-income and high-income countries.

68 lypill trials (9059 participants) done in 32 countries.

69 ess to reliable, high-quality testing across countries; (4) strengthening national leadership, with p

70 through December 2016, at 59 centers in five countries, 4994 patients underwent randomization and 491

71 t Demographic and Health Survey data from 58 countries (847685 surveys) were used to classify househo

72 is dominated by its incidence in developing countries, accounting for >700,000 estimated deaths per

73 als, clinics, or community practices from 33 countries across six continents.

74 hild health, nutrition, and education in six countries across the east Asia-Pacific region.

75 group, phase 3 trial done at 152 sites in 21 countries, adults with HCC who tolerated sorafenib (>/=4

76 Our 167-country analysis of latitudinal gradients of heat, pover

77 onema pallidum that is endemic in low-income countries and and occurs at lower rates in middle-income

78 for 13- to 14-year-olds in 214 centers in 87 countries and for 6- to 7-year-olds in 132 centers in 57

79 ildbirth has been documented in low-resource countries and is a deterrent to facility utilization for

80 by means of an election data set covering 86 countries and more than 500 elections, and a separate da

81 ents were enrolled from 58 centres across 18 countries and randomly assigned (1:1) to receive second-

82 t driver of biodiversity loss in most of the countries and regions, with a global average of 40%; (iv

83 0 strains from 103 culture collections in 43 countries and regions.

84 ve Health and Research was distributed to 41 countries and territories in the Americas and 41 more in

85 cessation of tOPV by 12 May 2016 and 95% of countries and territories submitted detailed monitoring

86 that designated monitors in each of the 155 countries and territories visit all vaccine stores as we

87 s from clinical and mosquito samples from 10 countries and territories, greatly expanding the observe

88 isorders, has spread rapidly to more than 70 countries and territories.

89 -1) was done in 68 outpatient sites in seven countries and the second (COMPOSE-2) at 69 outpatient si

90 ve order will result in the weakening of our country and bolstering of our enemies.

91 e contemporarily recalibrated for the target country and can be used where laboratory measurements ar

92 per 100,000 person-years were calculated by country and sex.

93 adjusting for maternal age, ethnicity, birth country and weight, as well as infant gender, birth year

94 estimate NSP coverage were available for 57 countries, and for 60 countries to estimate OST coverage

95 were published in English, from high-income countries, and were done in populations with a history o

96 After adjustment for age, sex, country, and SCD phenotype, a low hemoglobin level was s

97 (UK), a representative high-income temperate country, and used these results to assess the potential

98 many water systems in low- and middle-income countries are nonfunctional.

99 Many countries are utilizing reclaimed wastewater for agricul

100 To model per capita protein intake in countries around the world under eCO2, we first establis

101 ported to several other African and European countries as well as the United States, with limited fur

102 No consistent within-country associations were observed (e.g., 1.05 [0.89-1.2

103 e associated with lower mortality and CVD in countries at different economic levels.

104 es (academic centres and hospitals) in eight countries (Australia, Belgium, Canada, France, Ireland,

105 ting neonatal intensive care units from four countries (Australia, Canada, India, United States) betw

106 according to age, sex, cause, and BMI in 195 countries between 1990 and 2015.

107 Cigarette price increases across 23 European countries between 2004 and 2014 were associated with 920

108 ion of potential beetle pests that may cross country borders through the SWPM pathway.

109 nd (COMPOSE-2) at 69 outpatient sites in six countries; both studies were done in Europe and the USA.

110 ND Model inputs for 7 low- and middle-income countries (Brazil, Colombia, Ecuador, Ghana, Mexico, Tan

111 d in the past 2 decades, mainly in developed countries but also in developing regions.

112 ese mutations are quite rare in most Western countries but not so in certain regions of Spain or othe

113 ed intakes of UPFDs in low- to middle-income countries but rather that this is driven by small indige

114 of terms cannot be used across all European countries, but allergy seasonality can be compared acros

115 Coverage varied widely between countries, but was most often low according to WHO indic

116 ifferences in risk of influenza death across countries by comparing GHE respiratory infection mortali

117 immunization schedules in 126 all OPV-using countries by the end of 2015.

118 (1) number of people living with HIV in the country by end of 2013; (2) proportion of stage 1 ever d

119 re-analysis of the Canadian data from the 13-country case-control Interphone Study (2001-2004), in wh

120 e burden have been reported from high-income countries compared with reports from low-income and midd

121 cember 31, 2014, of infant populations in 23 countries (comprising 276 subnational regions) within th

122 ctices, and clinical research centers) in 14 countries conducted between December 2013 and December 2

123 to other sampled groups in their respective countries, consistent with their current practices of en

124 In a developing-country context, the International Monetary Fund (IMF) p

125 material and field collections from over 30 countries covering its known geographic range.

126 oss domestic product can be double what some countries currently spend on health.

127 alth challenge in the most severely affected countries despite the sharp decline in new cases in rece

128 extremely peaceful and extremely conflictual countries display lower stereotype ambivalence, whereas

129 We estimated DALYs for 195 countries divided into 21 world regions, in both sexes a

130 In Western countries emergence of human immunodeficiency virus (HIV

131 liminating measles by 2012; to this end, the country enhanced its mandatory vaccination programs and

132 in pesticide suicides and, in three of these countries, falls in overall suicide mortality.

133 of micro and macro variables but also within-country flow of funds and labor migration.

134 17 salt brands originating from 8 different countries followed by the identification of their polyme

135 ion of 5 x 5 km grid cells across 46 African countries for 2000, 2005, 2010, and 2015.

136 significant differences between regions and countries for many of the parameters evaluated.

137 d describe the global guidelines provided to countries for the safe and appropriate disposal of tOPV.

138 le in 14%-41% of level 2 facilities in the 3 countries for which there were data.

139 using permuted blocks and was stratified by country, gender, and Follicular Lymphoma International P

140 s higher, and that were located in wealthier countries, had higher social media use.

141 Introduction in the remaining 2 countries has been delayed because of the global shortag

142 y and mortality among young infants, several countries have recommended universal tetanus, diphtheria

143 rammes at primary health centres in European countries hosting Latin American migrants.

144 premature death and disability in low-income countries; however, few receive optimal benzathine penic

145 from 20 prospective cohort studies from ten countries (Iceland, the Netherlands, the USA, Taiwan, th

146 of polio assets alone, 6 out of the 10 focus countries improved coverage in three doses of diphtheria

147 ls over 2 years across 9 research sites in 7 countries in Africa and Asia.

148 ls, clinics, and academic institutions in 14 countries in Europe, Asia-Pacific, and North America.

149 d data for prison suicides in 24 high-income countries in Europe, Australasia, and North America from

150 ating in 14 population-based cohorts from 10 countries in Europe.

151 ED), and there is variation within and among countries in how these conditions are managed.

152 screened and enrolled at 119 hospitals in 11 countries in North America and Europe.

153 nt but focus on the median depth for the 122 countries in our sample, accounting for 90% of the world

154 ocation-specific population groups across 22 countries in the International Consortium on Mammographi

155 The recent spread of ZIKV to countries in the Western Hemisphere is associated with r

156 contemporary reassessment in one of the few countries in the world with a nationally representative

157 Japan was the first country in the world to introduce criteria for recognizi

158 e of the tomato virome in China, the leading country in tomato production.

159 Although data from two countries include male sex workers, the numbers are so s

160 is a serious invasive forest pest in several countries including the United States, Canada, and Europ

161 The number of participating countries increased fivefold (from 19 to 96).

162 In many developing countries, increased use of fertilizers is a response to

163 tions (eight studies of restrictions in five countries- India, Denmark, Ireland, the UK and the USA).

164 Epidemiological evidence from developed countries indicates that Helicobacter pylori infection c

165 isplay lower stereotype ambivalence, whereas countries intermediate on peace-conflict present higher

166 , and the infectious disease burden in these countries is another reason to step up global efforts to

167 is (ABM) in adults residing in resource-poor countries is associated with mortality rates >50%.

168 reduced environmental impact in high-income countries is driven by reductions in calories ( approxim

169 useful kidneys, but their retrieval in many countries is infrequent.

170 Comparability of population surveys across countries is key to appraising trends in population heal

171 ction of diabetes and infections in tropical countries is needed, and the infectious disease burden i

172 Further validation in other countries is needed.

173 ability to settings in low and middle income countries is questionable.

174 ecific pesticides (12 studies of bans in six countries-Jordan, Sri Lanka, Bangladesh, Greece [Crete],

175 dressing global public health threats at the country level reinforces the national immunization progr

176 For the 13- to 14-year-olds, the country-level eczema prevalence was positively and linea

177 raw material supply discussions by providing country-level information on three important minor metal

178 was positively and linearly associated with country-level monthly mean (prevalence ratio = 1.31 [95%

179 urrent monitoring programs that are based on country-level reporting or aggregate measures of emissio

180 ates the potential for global, regional, and country-level resource recovery to impact nutrient and h

181 be time trends in Europe, while allowing for country-level variability.

182 Our study limitations are the country-level variations in both surveillance methods an

183 entrations than low-income and middle-income countries (LMICs) and different sources of pollution.

184 women living in low-income and middle-income countries (LMICs), where opportunities for prevention, e

185 HIV-AIDS epidemic in low- and middle-income countries (LMICs).

186 he U.S. market in 2015, but its use in other countries may continue.

187 emissions from cookstoves used in developing countries may make important contributions to their clim

188 retrieved by literature review and included countries' mean patient TB-related costs, mean household

189 pulation aged 15-64 years, an increase of 31 countries (mostly in sub-Saharan Africa and the Pacific

190 As countries move towards detecting the 3 million tuberculo

191 osis were conducted in 5 sub-Saharan African countries (Mozambique, Swaziland, South Africa, Uganda,

192 to demonstrate seasonality depending on the country - namely 'hay fever', 'allergy' and 'pollen' - s

193 ated health issues in low- and middle-income countries need to continue to prepare themselves to prev

194 European countries need to set a timeline for implementing lung c

195 vel of disease surveillance integration in 3 countries (Nepal, India, and Nigeria) and proposes that

196 e carried out across two laboratories in two countries (New Zealand and China), and were designed to

197 envelope of US $45 million toward supporting countries not eligible for Gavi funding.

198 e for long-term maintenance in resource-poor countries of AFP surveillance as a platform for surveill

199 d 95% CIs, after adjusting for maternal age, country of origin, educational level, cohabitation with

200 ties from 2012 to 2014 in the low-endemicity country of Swaziland, we investigated the diagnostic acc

201 riteria, representing 10430 patients from 11 countries on 4 continents.

202 Evidence of IDU was recorded in 179 of 206 countries or territories, which cover 99% of the populat

203 from those either grown in other side of the country or foreign samples is represented by Mn content

204 e of deminers, if they were from high-income countries, or if they were of chemical weapons.

205 th poor survival were: being from an African countries other than Egypt (hazard ratio [HR] 1.59 [95%

206 Unanticipated concerns emerged from countries over acceptability of multiple injections, sit

207 under-recognised and underdiagnosed in most countries, particularly in girls and older children.

208 cannabis, following its legalization in some countries, poses emergent oral and periodontal health co

209 ng, planning, and implementation; and (3) in-country program communications and capacity building, to

210 ) to understand the extent of stock-outs, in-country purchasing, usage behavior, and breadth of avail

211 t 16, 2015, 270 patients from 63 sites in 11 countries received nivolumab, and 265 were evaluated for

212 21 producers in Brazil supplied to 60 other countries, reinforcing this view.

213 al therapy (ART), availability in low-income countries remains limited.

214 In practice, all countries reported cessation of tOPV by 12 May 2016 and

215 delivery in 50 (42%), 48 (51%), and 46 (49%) countries, respectively.

216 tions remains inadequate in resource-limited countries, resulting in high mortality and irrational us

217 hods Multidisciplinary investigators from 13 countries reviewed data from published trials performed

218 loads for temperatures that lie outside each country's currently observed temperature range.

219 ed randomly selected mean annual EMRs by the country's MRR and population.

220 nd to understand the effect on an individual country's programme.

221 y in the four U.S. states that bear half the country's TB burden: California, Florida, New York, and

222 ade by both sides that the ban will make our country safer, while others have argued that this execut

223 ently, there are 1,299 total cases from five country sites (Azerbaijan, Belarus, Moldova, Georgia, an

224 In the 9 developing country sites, nasopharyngeal/oropharyngeal swabs from c

225 n in polio transmission patterns by relating country-specific annual disease incidence to demographic

226 rom the posterior distribution of the sum of country-specific estimates to represent the range of pos

227 of the transition will depend largely on the country-specific prevalence of NNRTI resistance.

228 monly ingested pesticides in five of the six countries studied, including four studies using optimum

229 Country success stories include rapid increases in Kenya

230 ies between hip fracture trends in different countries suggests variations of the same epidemic.

231 Seven countries (Sweden, Cambodia, United Kingdom, Switzerland

232 notic influenza A virus subtype groups in 29 countries, Taiwan, and Hong Kong have caused human infec

233 ddress optimal prescribing, focusing on five countries that have developed different approaches to an

234 Low-income countries that introduce PCV13 with reasonable coverage

235 We restricted our analysis to 34 countries that reported more than 2,000 confirmations fo

236 England and Scotland), and the United States-countries that that differ in economic and inequity indi

237 ction of inactivated poliovirus vaccine in 3 countries that would make future NVIs more successful.

238 nce of asthma differs worldwide, and in many countries the prevalence is stable or decreasing.

239 In Western countries, the incidence of appendectomy steadily decrea

240 ndard drink equivalents per day of different countries, the WHO risk levels could also be used intern

241 to come from studies based in higher income countries, their external validity in terms of applicabi

242 Even though prohibited in Brazil and other countries, this antimicrobial reached fish.

243 ts distribution from England and these other countries to additional countries.

244 were available for 57 countries, and for 60 countries to estimate OST coverage.

245 residence [urban vs rural], and sex) in all countries to recruit eligible children aged 3-5 years fr

246 ted capability in most low- to middle-income countries to study the benefit of pneumococcal conjugate

247 ing the responses of one pest species in one country to one insecticidal protein from Bacillus thurin

248 We randomly assigned participants (1:1) by country to receive a subcutaneous injection of either me

249 efforts are needed, especially in developing countries, to ensure access to safe abortion.

250 2000-2014), weather variations in 103 source countries translated into asylum applications to the Eur

251 , making it unavailable to select lower-risk countries until the fourth quarter of 2017.

252 Industrialized countries (USA, UK, Germany, Japan, Italy, France and Ca

253 king prevalence (z = 2.55, p = 0.01) in each country, using World Health Organization data.

254 mated that the under-5 mortality rate in PMI countries was reduced from 28.9 to 24.3 per 1,000 person

255 rovement initiative in sepsis in an emerging country was associated with a reduction in mortality and

256 Cryptococcal antigenaemia prevalence by country was derived from 46 studies globally.

257 istics compared with patients from the other countries, we divided patients into two groups for analy

258 normalizing the residual load data for each country, we estimate a common dose-response function, wh

259 and August 2013 at 31 centers/groups from 20 countries were collected and retrospectively analyzed.

260 170 articles from 16 countries were included in analysis of efficacy of first

261 age, 33.2 [17.1] years) from 13 cohorts in 6 countries were included in the analysis.

262 clinical M. tuberculosis isolates from four countries were subjected to DST for eight drugs, confirm

263 ed pneumonia), enrolled at 136 centres in 23 countries, were randomly assigned (1:1) to 2000 mg cefta

264 among sex workers to the greatest extent in countries where enforcement is fair and effective.

265 esearch investments are typically highest in countries where funding for malaria control is also high

266 We examined prison suicide rates in countries where reliable information was available, asso

267 ) with clarithromycin-containing regimens in countries where the clarithromycin resistance rates were

268 t on cardiovascular disease, particularly in countries where this represents a major public health co

269 or infected travelers to spread the virus to countries where vectors are present and the population i

270 ess Initiative (CHAI) collected data from 14 countries (where it has active operations) to understand

271 pork tapeworm) is present in most developing countries, where it is a frequent cause of seizures and

272 ials done in 14 low-income and middle-income countries, which compared multiple micronutrient supplem

273 llution exposure have focused on high-income countries, which have much lower pollutant concentration

274 fective as in some of Germany's neighbouring countries, which, given present expenditure levels, indi

275 clinical trials enrolled individuals from 15 countries who were chronically infected with HCV genotyp

276 ied on representative samples of men in each country who were differentiated by their underlying reas

277 en expression and diversity, particularly in countries with 4CMenB programmes.

278 ).Anemia prevalence was approximately 40% in countries with a high infection burden and 12% and 7% in

279 -was evaluated among 13 616 patients from 38 countries with diabetes mellitus and known cardiovascula

280 ths for children younger than 5 years for 92 countries with high rates of mortality due to respirator

281 cific mortality to 2030 in 35 industrialised countries with high-quality vital statistics data.

282 d predominantly in France and Great Britain, countries with higher vaccine coverage rates.

283 ctions (SSTIs) in Denmark and other European countries with industrial pig production.

284 ompiled a database of 293,362 children in 35 countries with information on health, socioeconomic fact

285 detect and control bTB in Uruguay and other countries with low bTB prevalence.

286 3 to recommend genetic testing in France and countries with low to moderate incidence of melanoma, ex

287 th a high infection burden and 12% and 7% in countries with moderate and low infection burdens, respe

288 These epidemiological data identified countries with potentially increasing trends of liver ca

289 Across 94 countries with two or more survey datapoints, the popula

290 [95% CI, 8.9-15.6]), based on samples from a country with universal rotavirus vaccination.

291 oss per citizen shows large variations among countries, with higher values when per-capita income inc

292 widen the disparity in protein intake within countries, with plant-based diets being the most vulnera

293 tients from 300 general acute hospitals in 9 countries, with survey data from 26,516 registered nurse

294 e urban areas of 28 European cities, over 20 countries, with the aim of testing leaf deposited partic

295 To calculate death estimates for individual countries within each age-specific analytic division, we

296 E respiratory infection mortality rates from countries without EMR estimates with those with estimate

297 ve, phase 2/3 study, done at 107 centres (28 countries worldwide).

298 lled, phase 3 trial done in 97 centres in 25 countries worldwide.

299 , phase 3 trial was done in 87 centres in 21 countries worldwide.

300 ion of these viruses are ongoing in multiple countries, yet there is a dearth of mass rearing infrast